178 related articles for article (PubMed ID: 19452100)
21. Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.
Kaur PP; Derk CT; Chatterji M; Dehoratius RJ
J Rheumatol; 2004 Aug; 31(8):1663-5. PubMed ID: 15290751
[TBL] [Abstract][Full Text] [Related]
22. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
23. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Dadlani C; Orlow SJ
J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
[No Abstract] [Full Text] [Related]
24. Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.
Harley CR; Frytak JR; Tandon N
Am J Manag Care; 2003 Oct; 9(6 Suppl):S136-43. PubMed ID: 14577718
[TBL] [Abstract][Full Text] [Related]
25. Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate.
Darabi K; Jaiswal R; Hostetler S; Bechtel M; Zirwas M
J Drugs Dermatol; 2009 Feb; 8(2):175-8. PubMed ID: 19213235
[TBL] [Abstract][Full Text] [Related]
26. Borreliosis in a patient treated with anti-TNFα therapy: first case.
Bonnet N; Guis S; Drancourt M; Brouqui P; Berbis P
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):367-8. PubMed ID: 20524947
[No Abstract] [Full Text] [Related]
27. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW
J Rheumatol; 2006 May; 33(5):854-61. PubMed ID: 16541481
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
30. [Extranodal NK/T-cell lymphoma, nasal type, developed in a patient with rheumatoid arthritis].
Arai H; Maki K; Tadokoro J; Nakamura Y; Sasaki K; Mitani K
Rinsho Ketsueki; 2011 Jul; 52(7):551-5. PubMed ID: 21821989
[TBL] [Abstract][Full Text] [Related]
31. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Martin Mola E; Pedersen R; Robertson D; Chang D; Koenig A; Freundlich B;
Ann Rheum Dis; 2009 Jul; 68(7):1113-8. PubMed ID: 18718986
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
34. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S
Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074
[TBL] [Abstract][Full Text] [Related]
35. Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-alpha.
Fitch PG; Cron RQ
J Rheumatol; 2006 Apr; 33(4):825; author reply 826-7. PubMed ID: 16583487
[No Abstract] [Full Text] [Related]
36. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
37. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
[TBL] [Abstract][Full Text] [Related]
38. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
39. [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].
Pontikaki I; Gerloni V; Gattinara M; Luriati A; Salmaso A; De Marco G; Teruzzi B; Valcamonica E; Fantini F
Reumatismo; 2006; 58(1):31-8. PubMed ID: 16639486
[TBL] [Abstract][Full Text] [Related]
40. Patient preferences for treatment of rheumatoid arthritis.
Fraenkel L; Bogardus ST; Concato J; Felson DT; Wittink DR
Ann Rheum Dis; 2004 Nov; 63(11):1372-8. PubMed ID: 15020312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
